LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹208 Cr |
| Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹151 Cr | -7.93 | |
| Mar2023 | ₹164 Cr | -21.66 | |
| Mar2022 | ₹209 Cr | 0.63 | |
| Mar2021 | ₹208 Cr | -9.16 | |
| Mar2020 | ₹229 Cr | - | |
Compare Total Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹32.9 Cr | 9.9% | -16.7% | -63.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 9.9% |
-16.7% |
-63.2% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses